Screener
60 Degrees Pharmaceuticals SXTP Q3 2025 earnings
Reported November 13, 2025 · Before market open
Revenue$437.6KBeat by $237.6K
EPS-$2.64Miss by $0.80
Revenue estimate$200.0K
EPS estimate-$1.84
Next report
Nov 12, 2026 (in 2 months)Revenue estimate$270.0K
EPS estimate-$0.61
Versus estimates
Revenue
Diluted EPS
FAQ
- When did 60 Degrees Pharmaceuticals report Q3 2025 earnings?
- 60 Degrees Pharmaceuticals (SXTP) reported Q3 2025 earnings on November 13, 2025 before market open.
- What were 60 Degrees Pharmaceuticals's Q3 2025 revenue and EPS?
- 60 Degrees Pharmaceuticals reported revenue of $437.6K and eps of $-2.64 for Q3 2025.
- Did 60 Degrees Pharmaceuticals beat estimates in Q3 2025?
- Revenue beat the consensus estimate of $200.0K by $237.6K. EPS missed the consensus estimate of $-1.84 by $0.80.
- How did 60 Degrees Pharmaceuticals's Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 223.4% from $135.3K a year earlier and eps grew 43.2% from $-4.65.
- Where can I find 60 Degrees Pharmaceuticals's Q3 2025 SEC filings?
- You can read the 10-Q periodic report (0001554855-25-002032) directly on SEC EDGAR. The filing index links above go to sec.gov.
